Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 5/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.68 |
| ▸ | RECQL | P46063 | 2/20 | 0.68 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.68 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.68 |
| ▸ | GNG2 | P59768 | 1/20 | 0.55 |
| ▸ | GNB1 | P62873 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3996680 | 0.99 | FTO (0.67) | FTOMAPTMEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL9650959 | 0.99 | FTO (0.67) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL6812913 | 0.92 | FTO (0.65) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL8417782 | 0.90 | FTO (0.70) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL3510722 | 0.89 | FTO (0.68) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL4838173 | 0.89 | FTO (0.68) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL7212008 | 0.89 | GNG2 (0.69) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL78588 | 0.87 | FTO (0.53) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL5066567 | 0.86 | FTO (0.74) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL8714832 | 0.86 | FTO (0.64) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1810976-B1 | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND USE THEREOF | FUJIFILM CORP (JP) | 2014-08-27 | — | — | EP | claimed |
| US-20080027144-A1 | Benzonaphthacene Glycoside Derivative and Use Thereof | FUJIFILM CORPORATION (JP) | 2008-01-31 | — | — | US | claimed |
| EP-1882938-A2 | Method and apparatus for the fast determination of deoxynivalenol in a cereal-based matrix | Barilla G. e R. Fratelli S.p.A. (IT) | 2008-01-30 | — | — | EP | claimed |
| WO-2007122602-A1 | A METHOD AND SYSTEM FOR MEASURING MEMBRANE POTENTIAL BASED ON FLUORESCENCE POLARIZATION | SENG ENTERPRISES LTD. (CY) | 2007-11-01 | — | — | WO | claimed |
| US-20070254276-A1 | Method and system for measuring membrane potential based on fluorescence polarization | SENG ENTERPRISES LTD. (CY) | 2007-11-01 | — | — | US | claimed |
| EP-1810976-A1 | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND USE THEREOF | FUJIFILM Corporation (JP) | 2007-07-25 | — | — | EP | claimed |
| US-6794158-B2 | FLUORESCENT PROBE FOR USE AS DIAGNOSTIC TOOL IN MONITORING PREFERENTIAL ENZYME ACTIVITY | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-09-21 | — | — | US | claimed |
| US-20030082665-A1 | Fluorescence polarization assay | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2003-05-01 | — | — | US | claimed |
| WO-2002082082-A2 | FLUORESCENCE POLARIZATION ASSAY | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-10-17 | — | — | WO | claimed |
| EP-0702689-A4 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LAB (US) | 1997-10-22 | — | — | EP | claimed |
| WO-1993020074-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR ACRIDINE-9-CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | claimed |
| EP-0279213-B1 | FLUORESCENCE POLARIZATION IMMUNOASSAY FOR AMPHETAMINE/METHAMPHETAMINE | ABBOTT LABORATORIES (US) | 1992-10-21 | — | — | EP | claimed |
| US-5145791-A | Immunology | ABBOTT LABORATORIES (US) | 1992-09-08 | — | — | US | claimed |
| US-5145790-A | Immunoassay, fluorescein derivative | ABBOTT LABORATORIES (US) | 1992-09-08 | — | — | US | claimed |
| US-5096838-A | Fluorescent tracers for detection of barbiturates and for antiserums | ABBOTT LABORATORIES (US) | 1992-03-17 | — | — | US | claimed |
| EP-0455058-A2 | Reagents and method for detecting polychlorinated biphenyls | ABBOTT LABORATORIES (US) | 1991-11-06 | — | — | EP | claimed |
| US-4868132-A | BINDING TO A FLUORESCEIN TYPE TRACER, PRETREATMENT WITH PERIODATE | ABBOTT LABORATORIES (US) | 1989-09-19 | — | — | US | claimed |
| EP-0252404-A2 | 5-Hydroxy-3-indoleacetic acid fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1988-01-13 | — | — | EP | claimed |
| EP-0252405-A2 | 3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1988-01-13 | — | — | EP | claimed |
| EP-0201751-A2 | 4'-aminomethyfluorescein derivatives for use in fluorescence polarization immunoassys | ABBOTT LABORATORIES (US) | 1986-11-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027144-A1 | Benzonaphthacene Glycoside Derivative and Use Thereof | SORD, PSAT1, SBDS | FTO 645/4885MAPT 1873/4885MEN1 2746/4885 |
| US-20030082665-A1 | Fluorescence polarization assay | EPHX1, EPHX2, LTA4H | FTO 539/4885MAPT 4854/4885MEN1 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.